The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial.
This study evaluated the longitudinal effect of fish oil in pregnancy on breast milk fatty acid composition and infant outcomes. In a randomized, controlled trial, 98 women received 2.2 g docosahexaenoic acid (DHA) and 1.1 g eicosapentaenoic acid (EPA) or olive oil from 20 wk of gestation until delivery. Fatty acid composition in breast milk (at 3 d, 6 wk, and 6 mo) and infant erythrocyte membranes (at 1 y) were determined by gas liquid chromatography. Breast milk fatty acids were examined in relationship to growth and development. Compared with control group, breast milk from women who received fish oil had proportionally higher DHA and EPA levels at 3 d and 6 wk after delivery, but this difference was no longer apparent by 6 mo. Infant DHA status at 1 y of age was directly related to DHA levels at 3 d, 6 wk, and 6 mo postpartum (but not to antenatal supplementation). Both EPA and DHA in breast milk were positively correlated with Griffith's developmental scores including hand and eye coordination. Thus, supplementation in pregnancy was associated with increased n-3 long-chain polyunsaturated fatty acids (LCPUFAs) in breast milk, particularly in early lactation, and this was positively associated with infant DHA status at 1 y.
Dunstan
Janet A
JA
School of Paediatrics and Child Health, The University of Western Australia, Crawley WA 6009.
Mitoulas
Leon R
LR
Dixon
Glenys
G
Doherty
Dorota A
DA
Hartmann
Peter E
PE
Simmer
Karen
K
Prescott
Susan L
SL
D000328:Adult; D001827:Body Height / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D001942:Breast Feeding; D002508:Cephalometry; D019587:Dietary Supplements; D004281:Docosahexaenoic Acids / Q000378:metabolism / Q000494:pharmacology*; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000378:metabolism / Q000494:pharmacology*; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005865:Gestational Age; D006257:Head / Q000254:growth & development; D006801:Humans; D007223:Infant; D007227:Infant Nutritional Physiological Phenomena; D007774:Lactation / Q000187:drug effects* / Q000378:metabolism; D008137:Longitudinal Studies; D008895:Milk, Human / Q000187:drug effects* / Q000378:metabolism; D000069463:Olive Oil; D010938:Plant Oils / Q000494:pharmacology*; D011247:Pregnancy; D039401:Prenatal Nutritional Physiological Phenomena; D011597:Psychomotor Performance / Q000187:drug effects; D013997:Time Factors; D014705:Verbal Behavior / Q000187:drug effects
D000069463:Olive Oil; D010938:Plant Oils; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid